Mangrove Partners
SBCWW icon

Mangrove Partners’s SBC Medical Group Warrants SBCWW Stock Holding History

Mangrove Partners’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-930,091
Closed -$11.8M – 152
2024
Q1 		$11.8M Hold
930,091
– – 0.82% 37
2023
Q4 		$10M Hold
930,091
– – 0.68% 48
2023
Q3 		$9.9M Hold
930,091
– – 0.75% 46
2023
Q2 		$9.6M Hold
930,091
– – 0.66% 47
2023
Q1 		$9.7M Sell
930,091
-19,909
-2% -$1.29K 0.64% 43
2022
Q4 		$9.7M Buy
+950,000
New +$44.1K 0.55% 46

Other funds holding SBCWW

Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Shaolin Capital Management
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Schechter Investment Advisors
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AQR Arbitrage
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
Taconic Capital Advisors
Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
Periscope Capital
Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Mangrove Partners's SBCWW Position: Q2 2024 in Review

Mangrove Partners sold out of SBC Medical Group Warrants (SBCWW) in Q2 2024, closing a stake of 930,091 shares — an estimated $11.8M sold.

Mangrove Partners first reported a position in SBCWW in Q4 2022 and held it in 6 quarters. The position peaked at $11.8M in Q1 2024. 29 funds tracked by Wall St. Rank hold SBCWW as of Q2 2024.

  • Mangrove Partners reported no remaining SBC Medical Group Warrants position as of Q2 2024 after selling out during the quarter.
  • Mangrove Partners sold 930,091 SBC Medical Group Warrants shares in Q2 2024, an estimated $11.8M.
  • Mangrove Partners first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 6 quarters.
  • Mangrove Partners's SBC Medical Group Warrants position peaked at $11.8M in Q1 2024.
  • 29 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2024.

Based on Mangrove Partners's 13F filing for Q2 2024, filed 14 Aug 2024.